EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment

Di Wu iD, Zhifeng Yan, Mingxia Li, Mingyang Wang, Yuanguang Meng

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Di Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Carcinoma, Endometrioid, Endometrial Neoplasms, Machine Learning, Nomograms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) incidence and the associated tumour burden have increased globally. To build a molecular expression prognostic model based on the tumour microenvironment to guide personalised treatment using a machine learning approach. Two datasets were reviewed, including a training cohort ( n = 698) and a testing cohort ( n = 151). All patients underwent hysterectomy ± adnexectomy ± lymph nodes dissection between December 2014 and June 2020 at the PLA General Hospital First Medical Center and received necessary and regular follow‐up. We developed novel models using R software to predict factors that affect survival, such as progression‐free survival and overall survival. Then, the model was optimised by evaluating the prediction efficiency in multiple dimensions. Eight hundred and forty‐nine patients with EC were included in the study. Survival‐related influences on EC patients were identified by univariate analysis and cox regression equations. In addition, a nomogram was visualised in conjunction with demographic characteristics and the above meaningful clinicopathological variables. Ultimately, through a comprehensive assessment, a random forest model (RF16) was developed for complementing the findings of the molecular classification of EC. The RF16 not only specifically characterises tumour molecules, but also enhances the generalizability of the model by replacing gene sequencing with immunohistochemistry. This study showed that the machine learning model (RF16) is low‐cost, efficient, and clinically valuable in guiding treatment for EC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, EndometrioidEndometrial NeoplasmsMachine LearningNomogramsBiomarkers, TumorAdultAgedAged, 80 and overFemaleHumansMiddle AgedChinaRandom ForestRetrospective StudiesTumor Microenvironment

Stichwörter der Autor:innen

endometrial carcinomaimmunohistochemistrymachine learningmolecularprognosistumour microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Medicine, Nankai University, Tianjin, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Department of Obstetrics and Gynecology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Di Wu

Zitieren

APA

Wu, D., Yan, Z., Li, M., Wang, M., & Meng, Y. (2025). A Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70316

Vancouver

Wu D, Yan Z, Li M, Wang M, Meng Y. A Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70316

BibTeX
@article{Wu2025,
  author = {Wu, Di and Yan, Zhifeng and Li, Mingxia and Wang, Mingyang and Meng, Yuanguang},
  title = {A Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70316}
}
Kostenlos starten →